The FDA has approved a new treatment, Aucatzyl, for a type of aggressive blood cancer called B-cell acute lymphoblastic leukemia (B-cell ALL). This treatment, a CAR T-cell immunotherapy ...

The US Food and Drug Administration (FDA) has approved Shorla Oncology’s Imkeldi oral solution to treat certain forms of leukaemia and other cancers in adults and paediatric patients aged as young as ...

Acoramidis is the first FDA-approved treatment for ATTR-CM with near-complete TTR stabilization, reducing cardiovascular death and hospitalization. The phase 3 ATTRibute-CM trial showed acoramidis ...

These drugs are approved by the FDA for people with obesity and for people who are overweight and have certain medical conditions. Some supplements are sold as appetite suppressants, but they ...

The US Food and Drug Administration (FDA) has approved Autolus Therapeutics’ Aucatzyl (obecabtagene autoleucel) to treat acute lymphoblastic leukaemia (ALL). The CD19-directed CAR-T cell therapy has ...

Preserve your records, and 2. Pack your bags.” In the absence of meaningful regulation from the FDA, the supplement industry will no doubt take Kennedy’s stance as a free pass to relentlessly ...

as well as many other dietary supplements, are classed as "unapproved" drugs and have not undergone the same level of safety and efficacy scrutiny as approved pharmaceutical productions. "FDA is ...

Testing also revealed diclofenac, an FDA-approved drug known as a nonsteroidal ... and diclofenac cannot be marketed as dietary supplements. ZoomMax and ZapMax capsules are unapproved new drugs ...

as well as many other dietary supplements, are classed as "unapproved" drugs and have not undergone the same level of safety and efficacy scrutiny as approved pharmaceutical productions. "FDA is ...

Donald Trump’s pick for FBI director, Kash Patel, promoted a supplement line that purports without evidence to help people ...

The U.S. Food and Drug Administration announced a recall of Umary supplements due to a contamination of two over-the-counter ...